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Abstract:  Constipation is a symptom characterized by defecation frequency less than three times a week or fecal 
impaction. Chronic constipation is characterized by a sense of rectal dissatisfaction, bowel movement 
difficulty, or both. This literature review will explain the latest pathophysiology of constipation, diagnosis 
based on international clinical criteria (ROME III), and national consensus of the Indonesian Society of 
Gastroenterology, as well as the selection of evidence-based therapy. Factors causing chronic constipation 
include mechanical, metabolic, neuropathic, myopathic and idiopathic. Diagnosis needs to be systematically 
evaluated from anamnesis, identification of alarm symptoms, physical examination and investigation. 
Management of chronic constipation depends on the type of constipation. It is performed comprehensively 
to restore normal physiological defecation function and evaluate constipation causes. Constipation treatment 
may be pharmacological and non-pharmacological. Constipation complications include pelvic organ 
prolapse, hemorrhoids, hemorrhoid bleeding, fissure ani, fecal impaction causing colonic or stercoraceous 
ulcer obstruction, resulting in bleeding/perforation and recurrent urinary tract infections due to ureter 
compression due to stool mass. 
1 INTRODUCTION 
Constipation is a chronic gastrointestinal problem 
affecting a patient's quality of life (McCrea et al., 
2009; Sanchez and Bercik, 2011). The current 
pathophysiological mechanism shows a paradigm 
shift from idiopathic or functional to colonic 
neuropathology. Constipation by time is divided into 
acute less than 3 months and chronic constipation 
more than 3 months. This division is based on 
functional impairment of colon and anorectal 
function (Shah et al., 2008). The natural course of 
constipation has not been fully understood yet 
(Bharucha et al., 2013). 
Constipation incidence increases with the 
development of gastrointestinal motility diagnostics. 
A randomized cohort study from Olmsted Country, 
USA evaluated 4,176 subjects and reported an 
overall constipation prevalence of about 16% 
(Chang et al., 2010). Colonoscopy data of Cipto 
Mangunkusumo Hospital, Jakarta, Indonesia in 
1998-2005 showed that around 216 or 9% out of 
2,397 patients, were indicated as having 
constipation. Constipation prevalence in Asia, 
including South Korea, China, and Indonesia, is 
estimated to occur 15-23% in women and about 11% 
in men (Thomsen, 2010). 
The lack of pathophysiological knowledge 
becomes a major problem in constipation 
management. Instead of mechanical etiology, most 
societies consider chronic constipation a functional 
or idiopathic problem, including problems in the 
enteric nervous system. Constipation management 
needs thorough evaluation by anamnesis, physical 
examination and physiological tests (Gwee et al., 
2013). This literature review will explain the latest 
constipation pathophysiology and diagnosis based 
on international clinical criteria (ROME III), 
national consensus of the Indonesian Society of 
Gastroenterology and the selection of evidence-
based therapy. 
2 DEFINITION 
According to the American College of 
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Gastroenterology, constipation is rectal 
dissatisfaction characterized by infrequent bowel 
movements of less than three times in 1 week, 
difficulty in passing stools, or a combination of both. 
The definition of constipation based on the World 
Gastroenterology Organization 2007 practice 
guidelines distinguishes constipation based on 
symptoms experienced by patients and clinical 
evaluation. The constipation criteria based on 
clinical judgment are divided into functional 
constipation and Irritable Bowel Syndrome (IBS) 
constipation according to ROME III criteria as 
shown in Table 1 (Longstreth et al., 2006; Sanchez 
and Bercik, 2011). 
Table 1: Functional constipation based on ROME III 
(Longstreth et al., 2006) 
Minimum three months of complaint (minimum six 
months of complaint) 
Fulfilling minimum two criteria below: (minimum 
25% of defecation process) 
Straining 
Lumpy stools 
Unsatisfied feeling 
Anorectal dysfunction 
Manual maneuver to assist defecation (using fingers, 
support of pelvic floor muscle) 
<3 bowel movements per week 
Laxative use 
Fulfilling IBS criteria 
 
IBS is a recurrent pain or discomfort in the 
abdomen for at least 3 days per month in the last 3 
months, and it is associated with two or more of 
improved defecation, onset associated with changes 
in bowel movement frequency, and onset associated 
with changes in stool shape. The symptoms occur 
during the last 3 months with symptom onset at least 
6 months before the diagnosis (Camilleri, 2015). 
3 RISK FACTORS 
Factors causing chronic constipation include 
mechanical, metabolic, neuropathic, myopathic and 
idiopathic (functional). Mechanical causes can be 
detected through colonoscopy, such as tumors, 
intestinal strictures, anal fissures and 
intussusception. Metabolic causes include 
hypothyroidism, diabetes mellitus, hypercalcemia, 
hypokalemia and uremia. In addition, women, 
elderly, elderly pregnant women, lack of physical 
activity, low-calorie and fiber diet, low 
socioeconomic status, polypharmacy, physical and 
sexual violence, terminal stage, traveling, history of 
chronic constipation, psychological disorders and 
colonic inertia contribute to chronic constipation 
(Thomsen, 2010; Jamshed et al., 2011). 
4 TYPES OF CONSTIPATION 
Constipation by time is divided into acute 
constipation and chronic constipation. Furthermore, 
chronic constipation is divided into functional 
(primary) and secondary. Functional constipation, 
based on ROME III, is further classified into 
normal-transit constipation, slow-transit constipation 
and anorectal dysfunction or defecation (Basilisco 
and Coletta, 2013). 
4.1 Acute constipation 
Acute constipation has similar symptoms to chronic 
constipation, but with less than 3 months of 
complaint. This type of constipation is temporary 
due to psychological changes, dietary patterns, 
routine activities, opioid side-effects, postoperative, 
immobilization, colonic stricture and fecal 
impaction. Acute constipation is often asymptomatic 
without specific treatment (Rao SSC, 2016). 
4.2 Chronic constipation 
Chronic constipation is divided into primary and 
secondary. Primary constipation is further classified 
into normal-transit constipation, slow-transit 
constipation and anorectal dysfunction. No organic 
and biochemical abnormality is found in primary 
constipation. Factors affecting primary constipation 
are diet, impaired colonic motility, impaired 
absorption, motor anorectal, sensory function and 
psychological factors. The symptoms of primary 
constipation arise from the dysfunction between 
colonic regulation and stool movement, as well as 
the lack of anorectal neuromuscular coordination 
(Ghoshal, 2008). 
Secondary chronic constipation generally has 
organic abnormalities or other conditions as the 
basic foundation. The causes of secondary chronic 
constipation include extrinsic factors, mechanical 
obstruction, metabolic abnormalities, myopathy, 
neuropathy and conditions inhibiting the digestive 
tract (Wald, 2003; Thomsen, 2010). On the other 
hand, factors influencing secondary constipation are 
anatomical abnormalities (anorectal, colon disease), 
diet, drugs (opioids), metabolic disorders and 
Parkinson's disease (Basilisco and Coletta, 2013). 
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4.3 Slow-transit constipation 
This constipation is due to smooth colon’s muscle 
activity dysfunction, neurotransmitter, impaired cell 
activity in the colon and colon reflex dysfunction 
that subsequently slow intestinal contraction. In 
addition, there is a decrease in colon motor activity, 
impaired gastrocolic reflex and decreased sleep-
wake motor activity. These disorders will increase 
retrograde propulsion and nocturnal rectosigmoid 
motoric activity periodically that result in a 
deceleration of colonic propulsion process from the 
feces (Basilisco and Coletta, 2013). 
Table 2: Possible disorders causing chronic constipation 
(Thomsen, 2010) 
Extrinsic Mechanical 
obstruction
Metabolic 
condition
Lack of fiber 
or water 
Colon cancer Diabetes mellitus 
Intestinal 
flora 
imbalance 
External 
compression of 
malignant 
lesions 
Hypothyroidism 
Ignoring urge 
to defecate 
Stricture: 
diverticular/post-
ischemic 
Hypercalcemia 
Rectocele (if 
large) 
Hypokalemia 
Postoperative 
abnormalities 
Hypomagnesemia 
Megacolon Uremia 
Anal fissure Heavy metal 
poisoning 
Myopathy Other conditions Neuropathy
Amyloidosis Depression Parkinson’s 
disease 
Scleroderma Degenerative 
joint disease 
Spinal cord or 
tumor trauma
Autonomic 
neuropathy 
Cerebrovascular 
disease 
Cognitive 
impairment 
Multiple sclerosis 
Immobility Aganglionosis 
(Hirschsprung’s 
disease) 
 
Several studies have demonstrated a quantitative 
decrease in interstitial cells of Cajal (Wang et al., 
2008) and changes in the number of neurons in the 
myenteric plexus (Yik et al., 2011). The London 
classification reported hypoganglionosis, neuropathy 
inflammation, and degenerative leiomyopathy as 
some causes of slow-transit constipation (Knowles 
et al., 2010). The symptoms include the absence of 
contraction during defecation, abdominal 
discomfort, bloating and defecation frequency less 
than once per week. This type of constipation is 
most prevalent in young women, and causes colonic 
inertia complications. Management of slow-transit 
constipation includes aggressive laxatives, 
colectomy and ileorectal anastomosis (Wang et al., 
2008; Meurette et al., 2010). 
4.4 Anorectal dysfunction 
Anorectal dysfunction is characterized by functional 
anorectal abnormalities and anorectal anatomy 
characterized by resistance during defecation, long 
time to defecate, requiring digital maneuvers for 
fecal evacuation and obstructive defecation of liquid 
stools. Anorectal dysfunction is caused by 
dyssynergia, rectal intussusception or prolapse, 
rectocele and descending perineum syndrome. 
Patients with dyssynergia cannot coordinate their 
pelvic floor muscles, abdominal muscles and recto-
anal during defecation, resulting in hyposensitivity 
in the rectum (Rao, 2008; Basilisco and Coletta, 
2013). 
Anorectal dysfunction can be in the form of 
anorectal motor disturbance and sensory function, 
namely, a failure of external anal sphincter-
puborectalis relaxation when attempting defecation 
also known as anismus; a hypertonic internal anal 
sphincter; inadequate rectal propulsion; rectal 
hyposensitivity and hypotonicity; anatomical 
anorectal alterations (large rectoceles/prolapse 
rectum); excessive perineal descent perineum; and 
the uncoupling of the sensory component or the urge 
to defecate and the normal pre-defecatory motor 
activity of the colon (Basilisco and Coletta, 2013). 
5 DIAGNOSIS AND 
EVALUATION 
Systematic evaluations, including anamnesis, alarm 
symptom identification, physical examination and 
supportive evaluation, are needed for diagnosis 
(Thomsen, 2010). 
5.1 Anamnesis 
Initial anamnesis evaluates dietary fiber adequacy, 
fluid intake of at least 2 liters/24 hours and physical 
activity or exercise. Afterwards, it evaluates the 
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onset and duration of constipation symptoms, 
constipation characteristics including frequency, 
rectal sensation, obstructive defecation, 
accompanying gastrointestinal symptoms, 
comorbidities, drug use, immobilization, excessive 
stroke, use of digital maneuvers and stool 
consistency assessment based on the Bristol scale to 
predict the transit time (Leung et al., 2011). 
The alarm symptom signs in constipation 
include hematochezia, abdominal mass, a history of 
colorectal malignancy, family history of irritable 
bowel disease, significant weight loss, anorexia, 
chronic nausea and vomiting, first constipation and 
continues worsening, acute constipation in elderly 
and unidentified cause of anemia. Colonoscopy 
examination should be considered upon an alarm 
symptom sign (Thomsen, 2010). 
5.2 Physical examination 
Physical examination is systemically performed, 
starting with vital signs, nutritional status, 
abdominal examination, anorectal examination and 
neurological evaluation. The abdomen examination 
includes inspection of scar tissue, abdominal 
distension, palpation-percussion of abdominal mass, 
abdominal acute signs and auscultation in bowel 
sounds. Anorectal examination is conducted by 
inserting the index finger into the rectum to evaluate 
sphincter muscle condition, fecal presence and 
anorectal abnormalities such as stricture, hematoma, 
hemorrhoids, rectal prolapse, and tumor. 
Gynecological examination removes cysts or 
vaginal/uterus prolapse. Neurological examination is 
also necessary (Thomsen, 2010; Leung et al., 2011). 
Supportive evaluation to establish constipation 
diagnosis is conducted based on indications and 
needs, including (1) Laboratory: complete blood, 
glucose, creatinine, calcium, thyroid hormone, 
serum electrolytes, complete urine and fecal 
analysis. (2) Endoscopy: sigmoidoscopy and 
colonoscopy for identifications of narrowed lesion, 
intestinal obstruction and tissue retrieval for biopsy. 
Colonoscopy indications include 50-year-old 
patients without colon cancer screening, with 
symptom alarm, or history of surgery with 
constipation complaint. (3) Radiology: plain 
abdominal images, barium enema, CT 
colonography, to detect fecal retention in the colon, 
megacolon and aganglionic abnormalities. (4) 
Colorectal physiological examination with a colonic 
transit test if there is a rare complaint of chronic and 
refractory deficiency against laxative therapy. 
Colonic transit time is the time for a stool to pass 
through the colon. Methods used include the study 
of radiopaque markers or scintigraphy for measuring 
colonic transit quantitatively. (5) Wireless motility 
capsules (WMCs) assess regional abnormalities 
including gastric emptying, transit time in the small 
intestine, measure colonic transit, or whole gut 
transit time. It is conducted when there are refractory 
complaints concerning laxatives. WMCs have a 
sensitivity and specificity comparable to radiopaque 
marker examination or scintigraphy. WMCs are 
tolerated well, do not use contrast, have good patient 
compliance rates and avoid the risk of exposure to 
radiation, but are expensive. (6) Defecography can 
detect anatomical and functional anorectal 
abnormalities such as enterocele and 
intussusception. Its shortcomings are that it is 
difficult to perform in elderly with motility issues 
since the patient is embarrassed, dependent on the 
operator and less reliable. (7) Motility examination 
is in the form of anorectal manometry, colon 
manometry and balloon expulsion tests. Anorectal 
manometry can assess the function of the anal 
sphincter and pelvic floor reflex at rest and 
defecation, so it can diagnose dyssynergia during 
bowel movements. Colon manometry can evaluate 
intraluminal colon-rectum pressure activity, motor 
motility of colonic motility. (8) Another test is a 
barostat test for detecting anal hyposensitivity but is 
not routinely performed (Thomsen, 2010; Leung et 
al., 2011; Bharucha et al., 2013). 
6 MANAGEMENT 
Management of chronic constipation depends on the 
type of constipation. It is performed 
comprehensively to restore normal physiological 
defecation function and evaluate the cause of 
constipation. Constipation treatment may be 
pharmacological or non-pharmacological including 
lifestyle modification and surgery. Treatment may 
be given if there is no symptom alarm, age <40 
years, no abnormalities during rectal examination 
and no secondary etiology (Thomsen, 2010). 
6.1 Non-pharmacological 
Non-pharmacologic management of chronic 
constipation includes lifestyle modification with 
constipation education, dietary changes by 
increasing the consumption of high-fiber foods 
about 20-35 grams/day and drinking enough water at 
least 30-50 cc/kgBW/day for adult patients with 
normal activity, consuming probiotics 
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(Bifidobacterium sp.), increasing physical activity, 
regulating defecation habit such as avoiding 
straining, familiarizing defecation after meals to 
train post-prandial bowel movement reflexes, and 
avoiding drugs that cause constipation (Bharucha et 
al., 2013; Sbahi and Cash, 2015). 
6.2 Pharmacological 
Pharmacological therapy may be laxative and non-
laxative. Laxative therapy includes bulk laxatives 
such as psyllium, plantago ovata, and methyl 
cellulose; osmotic laxatives such as saline laxatives, 
magnesium hydroxide, sodium phosphate; absorbed 
disaccharide such as lactulose, sugar alcohol 
(sorbitol, mannitol, and polyethylene glycol), 
stimulant laxatives such as bisacodyl, castor oil, 
sodium picosulfate, and stool softener: dioctyl 
sodium sulfosuccinate; rectal enemas/suppositories 
such as bisacodyl, enema phosphate; and intestinal 
secretagogues such as lubiprostone, linaclotide, and 
plecanatide. 
Meanwhile, non-laxative treatments include 
prokinetics, bacteriotherapy or probiotics 
(lactobacillus and Bifidobacterium sp), and 
traditional therapy (Ford and Suares, 2011; Wald, 
2016). Further explanation is presented in Table 3. 
Figure 1: Constipation Diagnosis Algorithm (Bharucha et al., 2013) 
 
Management of opioid-induced constipation has 
been growing because of increased use of opioids. 
The gastrointestinal effects of opioids may delay 
gastrointestinal transit times, stimulate non-
propulsion motor activity, intestinal segmentation 
and increased tonus, increase fluid absorption by 
prolonging absorption time, and decrease electrolyte 
and water secretion into the intestinal lumen. This 
opioid effect works through three receptors, namely 
μ, κ, and δ. The main opioid mediation through μ 
receptors is found in the gut and central nervous 
system (Chey et al., 2014). Constipation therapy 
using opioid induction includes methylnaltrexone, 
alvimopan, and naloxegol (Siemens et al., 2015). 
Constipation management with a slow or normal 
transit time may be given a combination of stimulant 
and prokinetic laxative therapy (Bharucha et al., 
2013). 
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6.3 Surgery 
Surgical therapy is performed when neither a general 
therapy nor pharmacology response results. Surgical 
therapy includes colectomy and ileorectostomy. 
Subtotal colectomy with ileorectal anastomosis may 
improve chronic constipation complaints. The 
indication for subtotal colectomy is severe chronic 
constipation and does not respond to general or 
pharmacologic therapy; slow-transit constipation 
type of intestinal; no intestinal pseudo-obstruction; 
no pelvic floor dysfunction; no symptoms of 
dominant abdominal pain (Meurette et al., 2010; 
Sharma and Rao, 2017). Surgery is indicated if there 
are rectocele, intussusception and Hirschsprung, but 
persistent constipation symptoms (Sharma and Rao, 
2017). 
6.4 Biofeedback 
Biofeedback is a form of constipation management 
to train the patient to perform pelvic floor muscle 
relaxation during straining to restore normal 
defecation function. This exercise is noninvasive. 
Biofeedback may be given to constipation patients 
as well as with fecal incontinence. Biofeedback has 
been shown to improve rectal coordination during 
the defecation process and reduce constipation 
symptoms (Sbahi and Cash, 2015). 
7 COMPLICATIONS 
Constipation complications include alvi 
incontinence, organ pelvic organ prolapse, 
hemorrhoids, hemorrhoid bleeding, fissure ani, fecal 
impaction causing colonic or stercoraceous ulcer 
obstruction resulting in bleeding/perforation, and 
recurrent urinary tract infections due to ureteric 
compression due to stool mass (Thomsen, 2010;
Table 3: List of Pharmacological Laxative Therapies (Ramkumar and Rao, 2005). 
Laxative 
Class Medications Dosage 
Time to onset 
of action (h) Adverse effects Mechanism of action 
Bulk 
(fiber) 
Laxatives 
Psyllium 
 
calcium 
polycarbophil 
methylcellulose 
bran 
1 tsp up to 3 times daily 
2-4 tablets once daily 
1 tsp up to 3 times daily 
1 cup/day 
- 
 
- 
- 
- 
Flatulence, bloating, 
abdominal 
distension; rarely causing 
mechanical obstruction of 
esophagus and colon 
Retaining water in 
stools, increasing stool 
bulk and improving 
consistency 
Stool 
softeners 
Or 
wetting 
Agents 
Docusate sodium 100 mg twice daily 12-72 Intestinal cramping; 
irritation of 
throat (liquid 
formulation) 
Promoting luminal 
water binding by 
detergent-like action, 
increasing stool bulk 
Sorbitol 15-30 ml once daily or twice 
daily. 
24-48 
Lactulose 15-30 mL once daily or 
twice daily 
24-48 
PEG 8-32 oz once daily 0.5-1
Stimulant 
laxatives 
Glycerin Suppository, up to once 
daily 10 mg, 0.25-1
Abdominal discomfort, 
rarely 
electrolyte disturbance, 
melanosis coli 
Increasing intestinal 
peristalsis by acting on 
the myenteric nerve 
plexus, decreasing 
large intestinal water 
absorption 
Bisacodyl 
suppositories or 5-10 mg 
orally up to 3 times/wk 0.25-1
Picosulfate 
anthraquinones 
Senokot 
2 tablets once daily to 4 
tablets twice daily. 
8-12 
Perdiem 1-2 tsp 8-12
Peri-colace 1-2 tablets once daily 8-12
Saline 
laxatives 
Magnesium 15-30 mL once daily or 
twice daily 
1-3 Bloating, flatulence, 
abdominal cramping; in 
rare instances, electrolyte 
disturbance 
Osmotic water binding 
Enemas Mineral oil retention 199-250 mL once daily 6-8  
Tap water 500 Ml 5-15 min  
Phosphate 1 unit 5-15 min  
soapsuds 1500 Ml 2-15 min  
Mixed 
laxatives 
Dried plums  Flatulence, bloating Stool bulking and 
osmotic action 
 
(Leung et al., 2011). 
SIPS 2017 - Surabaya International Physiology Seminar
402
8 CONCLUSION 
Constipation is often found in everyday practice in 
all age groups, resulting in inhibiting activity. 
Constipation is a symptom characterized by 
defecation frequency less than three times a week or 
fecal impaction. Chronic constipation is 
characterized by a sense of rectal dissatisfaction, 
bowel movement difficulty, or both. The definition 
of constipation is based on ROME III, and clinicians 
should ensure adequate fluid intake, a high-fiber diet 
and adequate physical activity prior to management. 
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